NCT02502175View on ClinicalTrials.gov

Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

March 8, 2018

Study Completion Date

March 8, 2018

Conditions
Opioid Dependence
Interventions
DRUG

opium

Opium tincture (10mg/ml), manufactured by Daroupakhsh.co, Tehran, Iran.

DRUG

methadone

Methadone (5mg/ml), manufactured by Daroupakhsh.co, Tehran, Iran.

Trial Locations (4)

Unknown

Dodange Substance use disorder treatment center, Moḩammadābād

Kian substance use treatment center, Sari

Tavalodi Digar, Isfahan

Rooz-e-No substance use treatment center, Shiraz

All Listed Sponsors
collaborator

Tehran University of Medical Sciences

OTHER

collaborator

Iran National Science Foundation

UNKNOWN

collaborator

AJA University of Medical Sciences

OTHER

lead

University of British Columbia

OTHER

NCT02502175 - Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder | Biotech Hunter | Biotech Hunter